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Prevalence and risk factors of 
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Because healthcare workers (HCWs) are at high risk for tuberculosis (TB) infection, it is essential to 
research the prevalence of latent TB infection (LTBI) and to implement health interventions including 
early treatment of LTBI and TB infection control measures. The purpose of the study was to determine 
the prevalence and risk factors for LTBI using interferon-γ release assay (IGRA) among HCWs in South 
Korea. The cross-sectional study was carried in the National Health Insurance Service Ilsan Hospital, 
which is a 740-bed general hospital, South Korea. HCWs who participated in this survey were required 
to complete a questionnaire and IGRA was performed. Of the 1,655 HCWs, 271 results were positive 
and the prevalence of LTBI was 16% (95% CI; 15–18%). In the multivariate analysis, age (OR; 2.201, 
95% CI; 1.911–2.536, P < 0.001), male sex (OR; 1.523, 95% CI; 1.133–2.046, P = 0.005), contact active 
TB patients (OR; 1.461, 95% CI; 1.061–2.010, P = 0.02) and diabetes (OR; 2.837, 95% CI; 1.001–8.044, 
P = 0.05) were significant risk factors for LTBI. LTBI among HCWs in Korea, although prevalent, might 
not exceed the background level of the general population. Because contact with active TB patients has 
been identified as a risk factor for LTBI, more effective TB infection control measures are essential in 
healthcare facilities and congregate settings.
Despite the worldwide effort to control tuberculosis (TB), it remains a significant global health problem. 
According to the Global TB report 2016 by World Health Organization, TB was one of the top 10 causes of death 
worldwide1. In 2015, 10.4 million people developed TB and 1.8 million, including 0.4 million individuals with 
human immunodeficiency virus (HIV) infection, died from the disease1. Latent TB infection (LTBI) is a state in 
which a persistent immune response occurs to Mycobacterium tuberculosis without any clinical manifestations of 
active TB disease. Although the majority of persons with LTBI have no signs or symptoms of TB, they are at risk 
for developing active TB disease. Prevention of new M. tuberculosis infections and progression of LTBI to active 
TB disease is critical to reduce the burden of this disease.
Healthcare workers (HCWs) are at high risk for TB infection and some TB develops via in-hospital infec-
tion2. Because HCWs working in TB-related departments are at increased risk of developing TB3, it is essential 
to research the prevalence of LTBI in HCWs and to implement health interventions including early treatment of 
LTBI4,5 and TB infection control measures.
In South Korea, children undergo mandatory Bacille Calmette-Guérin (BCG) vaccination at birth6. For the 
diagnosis of LTBI, whole-blood interferon (IFN)-γ release assay (IGRA) is a better tool than the tuberculin skin 
test (TST), as TST has some limitations including the tendency of easily being affected by prior BCG vaccination7.
The purpose of the current study was to determine the prevalence and risk factors for LTBI using IGRA among 
HCWs in South Korea.
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Materials and Methods
Subjects and Settings. This cross-sectional study was carried out during an 18-month period, from July 
2015 to December 2016, in the National Health Insurance Service Ilsan Hospital, which is a 740-bed general hos-
pital in Goyang, South Korea. LTBI screening was performed to prevent nosocomial transmission according to 
The Korean Tuberculosis Prevention Act. Our subjects included all HCWs, including nurses, doctors, laboratory 
technicians, housekeeping staff, auxiliaries, administration staff, and pharmacists. We excluded HCWs with a 
history of tuberculosis.
Tools of the Study. Questionnaire. All HCWs who participated in this survey were required to complete 
a questionnaire. The questionnaire consisted of items related to age, sex, profession, working duration, current 
workplace, history of BCG vaccination, history of active TB, and medical history, including smoking, diabe-
tes, autoimmune disease, malignancy. Additional information obtained included history of employment in a 
TB-related department defined as the departments where HCWs with high possibility of contact with patients 
with respiratory tuberculosis are working according to Korea Centers for Disease Control and Prevention guide-
lines for managing tuberculosis of medical institutions; hospital ward or outpatient unit of pulmonology; hospi-
tal ward or outpatient unit of infectious diseases; bronchoscopy room; Mycobacterium tuberculosis laboratory; 
pulmonary function test room, intensive care unit; emergency department; pulmonology and allergy clinic of 
pediatrics; x-ray room of chest. Moreover, participating subjects provided their contact history with active TB, 
both within and outside of the hospital setting.
Interferon-γ release assay. QuantiFERON®TB Gold In-Tube (QFT-GIT; Qiagen, Germantown, USA) was per-
formed and results of the assay were interpreted according to the manufacturer’s instructions. For each case, three 
heparinized blood collection tubes were used. The first tube contained heparin alone (Nil tube, negative control), 
the second tube contained the T cell mitogen, phytohemagglutinin (mitogen tube, positive control), and the third 
tube contained three tuberculosis-specific antigens: ESAT-6, CFP-10, and TB7.7 (TB antigen tube). One-milliliter 
aliquots of blood were drawn directly into each tube and incubated at 37 °C for 24 hours, and then centrifuged 
and stored at 4 °C. The result of the IFN-γ assay was determined by measuring the IFN-γ in the TB antigen minus 
that in the negative control tube. When the level of TB antigen-Nil was >0.35 IU/mL and >25% of the Nil tube, 
results was considered as positive. If the mitogen-Nil was <0.5 IU/ml or the Nil was >8 IU/ml, results was con-
sidered as indeterminate. If the TB antigen was <0.35 IU/ml and mitogen control was ≥0.5 IU/ml, the test was 
considered negative.
Statistical analysis. Data were coded and statistically analyzed using the computerized software statistical pack-
age SPSS® version 23 (IBM®, Armonk, NY, USA). Dichotomous or categorical variables were compared using the 
χ2 test or the Fisher exact test, as appropriate. Logistic regression was performed to detect the main independent 
predictors for IGRA results. Variables with a P value of <0.1 in the univariate analysis were entered into a multi-
variate analysis using a backward elimination method.
Ethics. The study design was reviewed and approved by the Institutional Review Board of the National Health 
Insurance Service Ilsan Hospital, Gyeonggi-do, Korea with waived written informed consent (NHIMC 2017-01-
013). All methods in this study were performed in accordance with the Declaration of Helsinki.
Data availability. The datasets generated during the current study are available from the corresponding 
author on reasonable request.
Results
Characteristics of subjects. Of a total of 1,786 HCWs, 1720 (96%) completed the questionnaire and were 
included in the study. Of the 1,720 included HCWs, 65 (4%) were excluded from analysis because 63 had a history 
of active tuberculosis and two had indeterminate results with IGRA. Among 1,655 HCWs analyzed, 423 (26%) 
were male and 1,232 (74%) were female. The median age of the 1,655 HCWs was 33 years (interquartile range, 
26 y to 43 y). Regarding profession, 158 (10%) were doctors, 777 (47%) were nurses, 210 (13%) were technicians, 
331 (20%) were housekeeping staffs/auxiliaries, 155 (9%) administration staffs, and 24 (2%) were pharmacists. 
The median duration of employment was 51 months (interquartile range, 15 to 153), 1,081 (65%) had been vac-
cinated with BCG, 200 (12%) were smokers, 89 (5%) had a family history of TB, and 478 (29%) had contact with 
TB patients.
Prevalence and risk factors of latent tuberculosis among healthcare workers. Overall, of the 
1,655 HCWs, 271 results were positive on IGRA and the prevalence of latent TB diagnosed using IGRA was 
16% (95% CI; 15–18%). For the risk factors of LTBI, male sex (P < 0.001), age group (P < 0.001), profession 
(P < 0.001), working duration (P < 0.001), smoking (P < 0.001), diabetes (P < 0.001), and occupational exposure 
to risk area (P = 0.029) were found to be statically significant in the univariate analysis (Table 1). In the multivar-
iate analysis, age group (OR; 2.201, 95% CI; 1.911–2.536, P < 0.001), male sex (OR; 1.523, 95% CI; 1.133–2.046, 
P = 0.005), contact active TB patients (OR; 1.461, 95% CI; 1.061–2.010, P = 0.02) and diabetes (OR; 2.837, 95% 
CI; 1.001–8.044, P = 0.05) were significant risk factors for LTBI (Table 2).
Discussion
This study determined that the prevalence and risk factors of LTBI in HCWs by using IGRA.
In this study, we determined 16% of LTBI prevalence, which was similar to that of 17.2% in an earlier, mul-
ticenter study in South Korea8. Although another study reported higher prevalence of LTBI in South Korea 
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Male 101 (24) 322 (76) <0.001
Female 170 (14) 1062 (86)
Age group, y
≤29 35 (6) 587 (94) <0.001
30–39 69 (15) 403 (85)
40–49 101 (25) 297 (75)
≥50 66 (41) 97 (60)
Professions
Physician 38 (24) 120 (76) <0.001
Nurse 94 (12) 683 (88)
Technician 41 (20) 169 (80)
Housekeeping staff/Auxiliary 73 (22) 258 (78)
Administration staff 24 (15) 131 (85)
Pharmacist 1 (4) 23 (96)
Work duration, yr
≤1 46 (13) 318 (87) <0.001
>1 to ≤5 65 (12) 468 (88)
>5 to ≤10 31 (13) 205 (87)
>10 129 (25) 393 (75)
BCG vaccination
No 43 (17) 210 (83) 0.824
Yes 179 (17) 902 (83)
Unknown 49 (15) 272 (85)
Smoking
No 219 (15) 1236 (85) <0.001
Yes 52 (26) 148 (74)
Diabetes
No 263 (16) 1376 (84) <0.001
Yes 4 8 (50)
Autoimmune disease
No 269 (16) 1375 (84) 0.871
Yes 2 (18) 9 (82)
Malignancy
No 268 (16) 1377 (84) 0.243
Yes 3 (30) 7 (70)
Contact active tuberculosis patients
No 181 (15) 996 (85) 0.086
Yes 90 (19) 388 (81)
Work in risk area
No 189 (15) 1052 (85) 0.029
Yes 82 (20) 332 (80)
Table 1. Risk factors for latent tuberculosis detected via IGRA among healthcare workers: univariate analysis. 
IGRA; interferon-γ release assay.
Risk factor OR (95% CI) P value
Age group 2.201 (1.911–2.536) <0.001
Male sex 1.523 (1.133–2.046) 0.005
Diabetes 2.837 (1.001–8.044) 0.05
Contact active 
tuberculosis patients 1.461 (1.061–2.010) 0.02
Work in risk area 1.355 (0.979–1.876) 0.067
Table 2. Risk Factors for Latent Tuberculosis among Health care workers: Multivariate Analysis. OR, odds 
ratio; CI, confidence interval.
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(23.2%), a larger proportion of individuals with high-risk of exposure of another study could contribute to the 
difference in prevalence9.
In South Korea, prevalence of LTBI is variable. According to the seventh Korean National Health and 
Nutrition Examination Survey, 2016, the prevalence of LTBI was 33.2% (95% CI: 30.9–35.6). The prevalence was 
6.5% in the age group 10–19, 10.9% in 20–29, 36.4% in 30–39, 46.1% in 40–49, 48.7% in 50–59, 45.0% in 60–64 
although it is difficult to compare the prevalence rate with the present study because TST was used10. According 
to the Korea Centers for Disease Control and Prevention, the prevalence of LTBI in South Korea using the IGRA 
test ranged from 2.1% to 34%: 2.1% among first grade high school students (mean age 15.3), 2.9% among military 
conscripts, 15.2% among kindergarden teachers, 17.5% among HCWs (mean age 37.9), 19.3% among nursery 
workers (mean age 40.6), 28.5% among workers at social welfare facilities, and 34.0% among prisoners (mean age 
44.2). The difference in the prevalence rate was due to the age difference in the subject group, and there was no 
difference of age-specific prevalence. There was no difference according to occupation11.
Various risk factors, such as age8,12, history of close contact with a person with active TB12–14, work in high 
risk areas15, and employment duration as HCWs13, have been reported worldwide. In this study, we found several 
risk factors affecting the prevalence of LTBI by using IGRA. Increasing age, male sex, and contact with active TB 
patients were independently associated with LTBI. Despite the strict application of airborne precautions, contact 
with active TB patients has been identified as a risk factor for LTBI. This finding suggests that TB infection control 
measures in the hospital are still insufficient. To ensure that effective TB infection control measures are in place, 
the relative risk of TB in HCWs compared with the general population must be monitored.
To the best of our knowledge, this study was the largest, single center study to reveal the prevalence of LTBI 
and its related risk factors among HCWs in South Korea. IGRA is a superior tool over TST, especially in South 
Korea where BCG vaccination is mandatory6,8,9,16. Moreover, the vaccine policy until 1997, which stated that TST 
non-responders must be re-vaccinated with BCG at 12 years of age, may increase false positive rates of TST in 
South Korea17. For that reason, we used IGRA to determine the prevalence of LTBI in the study.
South Korea has high TB burden among high-income countries. The incidence of tuberculosis is highest from 
among the 34-member countries of the Organization for Economic Co-operation and Development (OECD). 
The incidence was 80/100,000 population in 2015, which was three times higher than that in Portugal, which 
reported the second highest incidence1. Reasons for the high burden of TB in South Korea include 1) high prev-
alence of LTBI in the elderly population; 2) inadequate patient management. In South Korea, LTBI should be 
detected for high risk HCWs by Tuberculosis Prevention Act since Aug 201618.
The global prevalence of LTBI was estimated at 23.0% in 2014. The South-East Asia Region had the highest 
prevalence of 30.8%19. The current lifetime risk of progression from LTBI to active TB disease is 5–15%20. Given 
the importance of LTBI in reducing the burden of disease and death caused by TB, detection and treatment of 
LTBI is critical1.
Because HCWs are at greater risk of TB infection and disease, and nosocomial outbreaks of multidrug-resistant 
TB and extensively drug-resistant TB have been documented, a comprehensive set of infection control measures 
such as administrative, environmental and personal protection measures, and periodic assessment of TB infec-
tion control is essential in healthcare facilities and congregate settings. Although we did not perform periodic 
assessments, data from this study can be used as baseline information.
This study had some limitations. First, TB skin tests were not performed, therefore, we could not compare 
the correlation of TB skin tests and IGRA. However, according to previous studies, IGRA is the better tool for 
diagnosis of LTBI. Second, although this was the large-scale study consisting of >1000 subjects and involving 
all types of hospital HCWs, the population was not representative of HCWs in South Korea because this was a 
single-center study.
In conclusion, this study reported a 16% prevalence rate of LTBI in HCWs by IGRA. LTBI among HCWs in 
Korea, although prevalent, might not exceed the background level of the general population. Because contact with 
active TB patients has been identified as a risk factor for LTBI, more effective TB infection control measures are 
essential in healthcare facilities and congregate settings.
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